Human skin morphology and dermal absorption

Dermal Absorption and Toxicity Assessment, Second Edition

Volumn , Issue , 2007, Pages 1-16

  Roberts, Michael S ^a   Walters, Kenneth A ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b An eX Analytical Services Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85056955833     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (64)

1. Flesh P, Kligman AM, Baldridge GD. Improved method for the separation of the epidermis of laboratory animals. J Invest Dermatol 1951; 16:86.
2. Kligman AM. A brief history of how the dead stratum corneum became alive. In:Elias PM, Feingold KR, eds. Skin Barrier. New York: Taylor & Francis, 2006;15-24.
3. Madison KC. Barrier function of the skin: “La raison d’etre” of the epidermis. J Invest Dermatol 2003; 121:231-41.
4. Walters KA, Roberts MS. The structure and function of skin. In:Walters KA, ed. Dermatological and Transdermal Formulations. New York: Marcel Dekker, 2002;1-39.
5. Monteiro-Riviere NA. Structure and function of skin. In:Riviere JE, ed. Dermal Absorption Models in Toxicology and Pharmacology. New York: Taylor & Francis, 2006;1-19.
6. Elias PM. Stratum corneum defensive functions: an integrated view. J Invest Dermatol 2005; 125:183-200.
7. Di Nardo A, Gallo RL. Cutaneous barriers in defense against microbial invasion. In:Elias PM, Feingold KR, eds. Skin Barrier. New York: Taylor & Francis, 2006;363-77.
8. Bouwstra JA, Pilgram GSK, Ponec M. Structure of the skin barrier. In:Elias PM, Feingold KR, eds. Skin Barrier. New York: Taylor & Francis, 2006;65-95.
9. Roberts MS, Cross SE, Pellett MA. Skin transport. In:Walters KA, ed. Dermatological and Transdermal Formulations. New York: Marcel Dekker, 2002;89-195.
10. Bronaugh RL, Maibach HI. Percutaneous Absorption. 4th ed. New York: Taylor & Francis, 2005.
11. Cross SE, Roberts MS. Dermal blood flow, lymphatics, and binding as determinants of topical absorption, clearance, and distribution. In:Riviere JE, ed. Dermal Absorption Models in Toxicology and Pharmacology. New York: Taylor & Francis, 2006;251-81.
12. Milstone LM. Epidermal desquamation. J Dermatol Sci 2004; 36:131-40.
13. Borradori L, Sonnenberg A. Structure and function of hemidesmosomes: more than simple adhesion complexes. J Invest Dermatol 1999; 112:411-8.
14. Fassihi H, Wong T, Wessagowit V, et al. Target proteins in inherited and acquired blistering skin disorders. Clin Exp Dermatol 2006; 31:252-9.
15. McMillan JR, Akiyama M, Nakamura H, et al. Colocalization of multiple laminin isoforms predominantly beneath hemidesmosomes in the upper lamina densa of the epidermal basement membrane. J Histochem Cytochem 2006; 54:109-18.
16. Aumailley M, El Khal A, Knoss N, et al. Laminin 5 processing and its integration into the ECM. Matrix Biol 2003; 22:49-54.
17. Kaiser HW, Ness W, Jungblut I, et al. Adherens junctions: demonstration in human epidermis. J Invest Dermatol 1993; 100:180-5.
18. Haftek M, Hansen MU, Kaiser HW, Kreysel HW, Schmitt D. Interkeratinocyte adherens junctions: immunocytochemical visualization of cell-cell junctional structures, distict from desmosomes, in human epidermis. J Invest Dermatol 1996; 106:498-504.
19. Hu P, Berkowitz P, O’Keefe EJ, et al. Keratinocyte adherens junctions initiate nuclear signalling by translocation of plakoglobulin from the membrane to the nucleus. J Invest Dermatol 2003; 121:242-51.
20. Chometon G, Zhang Z-G, Rubinstein E, et al. Dissociation of the complex between CD151 and laminin-binding integrins permits migration of epithelial cells. Exp Cell Res 2006; 312:983-95.
21. Vespa A, D’Souza SJA, Dagnino L. A novel role for integrin-linked kinase in epithelial sheet morphogenesis. Mol Biol Cell 2005; 16:4084-95.
22. Yoshida M, Yamasaki K, Daiho T, et al. ATP2C1 is specifically localized in the basal layer of normal epidermis and its depletion triggers keratinocyte differentiation. J Dermatol Sci 2006; 43:21-33.
23. Rigort A, Grunewald J, Herzog V, et al. Release of integrin macroaggregates as a mechanism of rear detachment during keratinocyte migration. Eur J Cell Biol 2004; 83:725-33.
24. Grando SA. Cholinergic control of epidermal cohesion. Exp Dermatol 2006; 15:265-82.
25. Chernyavsky AI, Arredondo J, Wess J, et al. Novel signalling pathways mediating reciprocal control of keratinocyte migration and wound epithelialization by M3 and M4 muscarinic receptors. J Cell Biol 2004; 166:261-72.
26. Nguyen VT, Arredondo J, Chernyavsky AI, et al. Keratinocyte acetylcholine receptors regulate cell adhesion. Life Sci 2003; 72:2081-5.
27. Nguyen VT, Chernyavsky AI, Arredondo J, et al. Synergistic control of keratinocyte adhesion through muscarinic and nicotinic acetylcholine receptor subtypes. Exp Cell Res 2004; 294:534-49.
28. Madison KC, Howard EJ. Ceramides are transported through the Golgi apparatus in human keratinocytes in vitro. J Invest Dermatol 1996; 106:1030-5.
29. Menon GK, Feingold KR, Elias PM. Lamellar body secretory response to barrier disruption. J Invest Dermatol 1992; 98:279-89.
30. Fartasch M, Bassukas ID, Diepgen T L. Disturbed extruding mechanism of lamellar bodies in dry non-eczematous skin of atopics. Br J Dermatol 1992; 127:221-7.
31. Pilgram GS, Vissers DC, van der Meulen H, et al. Aberrant lipid organization in stratum corneum of patients with atopic dermatitis and lamellar ichthyosis. J Invest Dermatol 2001; 117:710-7.
32. Bouwstra JA, Ponec M. The skin barrier in healthy and diseased state. Biochim Biophys Acta 2006; 1758:2080-95.
33. Norlen L. Skin barrier structure and function: the single gel phase model. J Invest Dermatol 2001; 117:830-6.
34. Norlen L, Gil IP, Simonsen A, et al. Human stratum corneum lipid organization as observed by atomic force microscopy on Langmuir-Blodgett films. J Struct Biol 2007; 158:386-400.
35. Plasencia-Gil MI, Norlen L, Bagatolli LA. Direct visualization of lipid domains in human skin stratum corneum’s lipid membranes: effect of pH and temperature. Biophys J 2007; 93:3142-55.
36. Hill J, Paslin D, Wertz PW. A new covalently bound ceramide from human stratum corneum-u-hydroxyacylphytosphingosine. Int J Cosmet Sci 2006; 28:225-30.
37. Bouwstra JA, Gooris GS, Dubbelaar FE, et al. Phase behavior of lipid mixtures based on human ceramides: coexistence of crystalline and liquid phases. J Lipid Res 2001; 42:1759-70.
38. Bouwstra JA, Dubbelaar FE, Gooris GS, et al. The lipid organisation in the skin barrier. Acta Derm Venereol Suppl (Stockh) 2000; 208:23-30.
39. Moore DJ, Snyder RG, Rerek ME, et al. Kinetics of membrane raft formation: fatty acid domains in stratum corneum lipid models. J Phys Chem B 2006; 110:2378-86.
40. Gooris GS, Bouwstra JA. Infrared spectroscopic study of stratum corneum model membranes prepared from human ceramides, cholesterol, and fatty acids. Biophys J 2007; 92:2785-95.
41. Bouwstra JA, Honeywell-Nguyen PL, Gooris GS, et al. Structure of the skin barrier and its modulation by vesicular formulations. Prog Lipid Res 2003; 42:1-36.
42. Honeywell-Nguyen PL, deGraaff AM, Groenink HW, et al. The in vivo and in vitro interactions of elastic and rigid vesicles with human skin. Biochim Biophys Acta 2002; 1573:130-40.
43. Honeywell-Nguyen PL, Gooris GS, Bouwstra JA. Quantitative assessment of the transport of elastic and rigid vesicle components and a model drug from these vesicle formulations into human skin in vivo. J Invest Dermatol 2004; 123:902-10.
44. El Maghraby GM, Williams AC, Barry BW. Skin delivery of oestradiol from deformable and traditional liposomes: mechanistic studies. J Pharm Pharmacol 1999; 51:1123-34.
45. Jain S, Jain N, Bhadra D, et al. Transdermal delivery of an analgesic agent using elastic liposomes: preparation, characterization and performance evaluation. Curr Drug Deliv 2005; 2:223-33.
46. Mishra D, Garg M, Dubey V, et al. Elastic liposomes mediated transdermal delivery of an anti-hypertensive agent: propranolol hydrochloride. J Pharm Sci 2007; 96:145-55.
47. El Maghraby GM, Williams AC, Barry BW. Can drug-bearing liposomes penetrate intact skin? J Pharm Pharmacol 2006; 58:415-29.
48. Dusek RL, Godsel LM, Green KJ. Discriminating roles of desmosomal cadherins: beyond desmosomal adhesion. J Dermatol Sci 2007; 45:7-21.
49. Getsios S, Amargo EV, Dusek RL, et al. Coordinated expression of desmoglein 1 and desmocollin 1 regulates intercellular adhesion. Differentiation 2004; 72:419-33.
50. Caubet C, Jonca N, Brattsand M, et al. Degradation of corneodesmosome proteins by two serine proteases of the kallikrein family, SCTE/KLK5/hK5 and SCCE/KLK7/hK7. J Invest Dermatol 2004; 122:1235-44.
51. Deraison C, Bonnart C, Lopez F, et al. LEKTI fragments specifically inhibit KLK5, KLK7, and KLK14 and control desquamation through a pH-dependent interaction. Mol Biol Cell 2007; 18:3607-19.
52. Borgono CA, Michael IP, Komatsu N, et al. A potential role for multiple tissue kallikrein serine proteases in epidermal desquamation. J Biol Chem 2007; 282:3640-52.
53. Wester RC, Noonan PK, Smeach S, Kosoboud L. Pharmacokinetics and bioavailability of intravenous and topical nitroglycerin in the rhesus monkey: estimates of percutaneous first pass metabolism. J Pharm Sci 1983; 72:745-8.
54. Magnusson BM, Anissimov YG, Cross SE, Roberts MS. Molecular size as the main determinant of solute maximum flux across the skin. J Invest Dermatol 2004; 122:993-9.
55. Magnusson BM, Cross SE, Winckle G, Roberts MS. Percutaneous absorption of steroids:determination of in vitro permeability and tissue reservoir characteristics in human skin layers. Skin Pharmacol Physiol 2006; 19:336-42.
56. Bucks D, Maibach H. Occlusion does not uniformly enhance penetration in vivo. In:Bronaugh RL, Maibach HI, eds. Percutaneous Absorption. 4th ed. New York: Marcel Dekker, 2005;81-105.
57. Potts RO, Guy RH. Predicting skin permeability. Pharm Res 1992; 9:663-9.
58. Roberts MS, Anissimov YG, Cross SE. Factors affecting the formation of a skin reservoir for topically applied solutes. Skin Pharmacol Physiol 2004; 17(1):3-16.
59. Vickers CFH. Existence of reservoir in stratum corneum. Experimental proof. Arch Dermatol 1963; 88:21-3.
60. Roberts MS, Walters KA. The relationship between structure and barrier function of skin. In:Roberts MS, Walters KA, eds. Dermal Absorption and Toxicity Assessment. New York: Marcel Dekker, 1998;1-42.
61. Levin J, Maibach H. The correlation between transepidermal water loss and percutaneous absorption: an overview. J Control Release 2005; 103:291-9.
62. Walters KA, Roberts MS, eds. Dermatological, Cosmeceutic, and Cosmetic Development:Therapeutics and Novel Approaches. New York: Informa Healthcare, 2008.
63. Chan KKH, Ross HD, Berner B, Piraino AJ. Pharmacokinetics of a single dose of nicotine in healthy smokers. J Control Rel 1990; 14:145-51.
64. European Medicines Agency. EPARs for authorised medicinal products for human use:scientific discussion. http://www.emea.europa.eu/humandocs/PDFs/EPAR/intrinsa/063406en6.pdf (last accessed 23 October, 2007).